Studies on patients who stopped tirzepatide showed significant weight regain within 12 months, and reduced metabolic rate from muscle loss likely contributes to that pattern
It does not interfere with GLP-1 or GIP receptor binding, does not alter tirzepatide pharmacokinetics, and does not compete for the same metabolic enzymes
Identifying which category applies to you helps justify the typically modest cost difference between glycine-containing and glycine-free compounded formulations
For more detail on nutrition alongside weight loss peptides, explore our guides on peptides for weight loss in women and fat-burning approaches for men
These combined effects can be particularly helpful for people with insulin resistance , a common feature of type 2 diabetes
If you are a provider seeking resources, please CONTACT US to obtain the password